9127047

Source:http://linkedlifedata.com/resource/pubmed/id/9127047

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0028833, umls-concept:C0031082, umls-concept:C0087111, umls-concept:C0220825, umls-concept:C0346302, umls-concept:C0443252, umls-concept:C2347167
pubmed:issue	4
pubmed:dateCreated	1997-6-24
pubmed:abstractText	To compare the changes in tumor volume with length of octreotide treatment in patients with acromegaly, to analyze signal alterations of the pituitary mass during treatment, and to determine an optimal MR imaging protocol.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8003708
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal, http://linkedlifedata.com/resource/pubmed/chemical/Contrast Media, http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations, http://linkedlifedata.com/resource/pubmed/chemical/Gadolinium, http://linkedlifedata.com/resource/pubmed/chemical/Gadolinium DTPA, http://linkedlifedata.com/resource/pubmed/chemical/Human Growth Hormone, http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor I, http://linkedlifedata.com/resource/pubmed/chemical/Meglumine, http://linkedlifedata.com/resource/pubmed/chemical/Octreotide, http://linkedlifedata.com/resource/pubmed/chemical/Organometallic Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Pentetic Acid
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	0195-6108
pubmed:author	pubmed-author:BurmanPP, pubmed-author:Edén EngströmBB, pubmed-author:KarlssonF AFA, pubmed-author:LundinPP
pubmed:issnType	Print
pubmed:volume	18
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	765-72
pubmed:dateRevised	2008-2-14
pubmed:meshHeading	pubmed-meshheading:9127047-Acromegaly, pubmed-meshheading:9127047-Adenoma, pubmed-meshheading:9127047-Adult, pubmed-meshheading:9127047-Aged, pubmed-meshheading:9127047-Antineoplastic Agents, Hormonal, pubmed-meshheading:9127047-Contrast Media, pubmed-meshheading:9127047-Drug Combinations, pubmed-meshheading:9127047-Evaluation Studies as Topic, pubmed-meshheading:9127047-Female, pubmed-meshheading:9127047-Follow-Up Studies, pubmed-meshheading:9127047-Gadolinium, pubmed-meshheading:9127047-Gadolinium DTPA, pubmed-meshheading:9127047-Hemorrhage, pubmed-meshheading:9127047-Human Growth Hormone, pubmed-meshheading:9127047-Humans, pubmed-meshheading:9127047-Image Enhancement, pubmed-meshheading:9127047-Insulin-Like Growth Factor I, pubmed-meshheading:9127047-Magnetic Resonance Imaging, pubmed-meshheading:9127047-Male, pubmed-meshheading:9127047-Meglumine, pubmed-meshheading:9127047-Middle Aged, pubmed-meshheading:9127047-Necrosis, pubmed-meshheading:9127047-Octreotide, pubmed-meshheading:9127047-Organometallic Compounds, pubmed-meshheading:9127047-Pentetic Acid, pubmed-meshheading:9127047-Pituitary Gland, pubmed-meshheading:9127047-Pituitary Neoplasms, pubmed-meshheading:9127047-Remission Induction
pubmed:year	1997
pubmed:articleTitle	Long-term octreotide therapy in growth hormone-secreting pituitary adenomas: evaluation with serial MR.
pubmed:affiliation	Department of Diagnostic Radiology, University Hospital, Uppsala, Sweden.
pubmed:publicationType	Journal Article, Comparative Study, Research Support, Non-U.S. Gov't